Bio-Techne (TECH) Tops Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% as AI buildout costs, Fed rate outlook weigh
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Bio-Techne Releases Second Quarter Fiscal 2018 Results
February 6, 2018 7:01 AM ESTMINNEAPOLIS, Feb. 6, 2018 /PRNewswire/ --Â Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ended December 31, 2017.
Second Quarter FY2018 Snapshot
Second quarter organic revenue increased by 14% (17% reported) to $154.2 million. GAAP EPS was $1.29 vs. $0.20 one year ago. GAAP EPS saw a one-time benefit of $0.94 from tax reform, largely due to the revaluation of deferred tax liabilities.... More